Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best Science Apps

More »
Apr 01, 2013 (Vol. 33, No. 7)

Protozoan Identification

  • Nice visual design, different types of activities
  • Small collection of exercises and photos/videos
Platform: iPad/iPhone  
Cost: $2.99

Can you tell a Synura from a Phacus? If not, then you need some protozoan practice…and the Protozoan Identification app by Carolina Biological Supply is here to help! The app is divided into four sections: dichotomous key, labeling activities, photo gallery, and video gallery. The photo and video galleries include a small collection of—you guessed it—photos and videos, respectively, of various protozoan critters such as types of flagellates and ciliates. The labeling section of the app provides three labeling exercises: a paramecium, a euglena, and an amoeba. For each organism there are diagrams with arrows pointing to specific anatomical features. In “study” mode these features are labeled; in “practice” mode the user provides the labels him/herself. Finally, the dichotomous key exercise has users identify seven organisms by watching a video of the organism and then answering a series of questions that will lead to an identity (correct or incorrect, depending on how you answer).

  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good

*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.


GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

What Does Brexit Mean for Biotech?

Do you agree with the contention that Brexit will NOT have a long-term negative impact on the British biotech industry?

More »